Special issue "The advance of solid tumor research in China": Discoidin domain receptor 2 promotes colorectal cancer metastasis by regulating epithelial mesenchymal transition via activating AKT signaling

Int J Cancer. 2023 Jan 1;152(1):51-65. doi: 10.1002/ijc.34227. Epub 2022 Sep 2.

Abstract

Tumor metastasis is one of the main reasons for the high mortality rate associated with colorectal cancer (CRC). However, its underlying mechanisms have not been fully understood. Here, we reported that the expression of discoidin domain receptor 2 (DDR2) was significantly upregulated in CRC tissues compared to that in normal adjacent tissues. The expression level of DDR2 was negatively associated with prognosis of CRC patients. Therefore, DDR2 may play an oncogenic role in CRC development. Furthermore, DDR2 induced epithelial mesenchymal transition in CRC cells and regulated their invasive and metastatic capacity in vitro and in vivo. Mechanistically, increased DDR2 expression level activated the AKT/GSK-3β/Slug signaling pathway. In conclusion, these findings showed that DDR2 promoted CRC metastasis and DDR2 inhibition might represent an effective therapeutic strategy for local advanced and metastatic CRC treatment.

Keywords: E-cadherin; colorectal cancer; discoidin domain receptor 2; metastasis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Cell Movement
  • Colorectal Neoplasms* / pathology
  • Discoidin Domain Receptor 2*
  • Epithelial-Mesenchymal Transition
  • Glycogen Synthase Kinase 3 beta / metabolism
  • Humans
  • Neoplasm Metastasis
  • Proto-Oncogene Proteins c-akt / metabolism
  • Signal Transduction

Substances

  • Discoidin Domain Receptor 2
  • Proto-Oncogene Proteins c-akt
  • Glycogen Synthase Kinase 3 beta